|
LSS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
8.53599999572907E-08 |
| Normal-vs-Stage3 |
2.79798406666032E-12 |
| Normal-vs-Stage4 |
4.55469995053193E-10 |
| Stage1-vs-Stage2 |
5.061600E-01 |
| Stage1-vs-Stage3 |
7.621800E-01 |
| Stage1-vs-Stage4 |
7.483000E-01 |
| Stage2-vs-Stage3 |
4.560000E-01 |
| Stage2-vs-Stage4 |
4.678600E-01 |
| Stage3-vs-Stage4 |
9.415000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.33066907387547E-16 |
| Normal-vs-AfricanAmerican |
1.24869999995614E-06 |
| Normal-vs-Asian |
1.02919999966922E-07 |
| Caucasian-vs-AfricanAmerican |
9.838200E-01 |
| Caucasian-vs-Asian |
2.826400E-01 |
| AfricanAmerican-vs-Asian |
4.800400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.78537218132169E-13 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
8.007400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63946634046397E-12 |
| Normal-vs-Age(41-60Yrs) |
1.30895294603306E-13 |
| Normal-vs-Age(61-80Yrs) |
2.76478839822403E-12 |
| Normal-vs-Age(81-100Yrs) |
9.600900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.271200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.714400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.474000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.356800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.753400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.620600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.986420E-01 |
| Classical-VS-Follicular |
1.957970E-01 |
| Classical-VS-Other |
3.448800E-01 |
| Classical-VS-Normal |
1.62814206561279E-12 |
| Tall-VS-Follicular |
7.887400E-01 |
| Tall-VS-Other |
7.735200E-01 |
| Tall-VS-Normal |
3.62910002049688E-09 |
| Follicular-VS-Other |
7.032800E-01 |
| Follicular-VS-Normal |
2.74039679837301E-11 |
| Other-VS-Normal |
1.837580E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.80109269112927E-13 |
| Normal-vs-N1 |
3.3539837573926E-12 |
| N0-vs-N1 |
5.757700E-02 |
|
|
